Relief Therapeutics: Funding, Investors & Team (Sep 2026)
Relief focuses primarily on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications. Its lead drug candidate RLF-100TM (aviptadil) is being investigated in two placebo-controlled U.S. late-stage clinical trials in respiratory deficiency due to COVID-19. Relief holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM.
Relief Therapeutics has raised $5.6M across 1 funding round on record, the most recent an undisclosed round of $5.6M announced in Jun 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Relief Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Relief Therapeutics Funding Rounds
Relief Therapeutics Founders and Leadership Team
Contact details for the Relief Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Relief Therapeutics Funding Compared to Other Biotechnology Startups
Relief Therapeutics' latest round of $5.6M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Relief Therapeutics in Biotechnology and Zürich
Companies Similar to Relief Therapeutics
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Relief Therapeutics Funding FAQs
What does Relief Therapeutics do?
Relief focuses primarily on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical testing and use in human patients or a strong scientific rationale. Currently, Relief is concentrating its efforts on developing new treatments for respiratory disease indications. Its lead drug candidate RLF-100TM (aviptadil) is being investigated in two placebo-controlled U.S. late-stage clinical trials in respiratory deficiency due to COVID-19. Relief holds a patent issued in the United States and various other countries covering potential formulations of RLF-100TM.
How much funding has Relief Therapeutics raised?
Relief Therapeutics has raised $5.6M across 1 round on record. The most recent is an undisclosed round of $5.6M announced in Jun 2023.
When did Relief Therapeutics last raise funding?
Relief Therapeutics' most recent funding round on record is an undisclosed round of $5.6M, announced in Jun 2023.
Who founded Relief Therapeutics?
FundedIQ lists Anthony Kim (Founder) at Relief Therapeutics.
Where is Relief Therapeutics headquartered?
Relief Therapeutics is based in Zürich, Zurich, Switzerland.
How many employees does Relief Therapeutics have?
Relief Therapeutics is in the 51-100 employee band.
How does Relief Therapeutics' funding compare to other Biotechnology startups?
Relief Therapeutics' latest round of $5.6M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Relief Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Relief Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.